Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Jul;60(1):5–8. doi: 10.1038/bjc.1989.208

Treatment of breast cancer with aromatase inhibitors--current status and future prospects.

P E Lønning 1, M Dowsett 1, T J Powles 1
PMCID: PMC2247352  PMID: 2679845

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barone R. M., Shamonki I. M., Siiteri P. K., Judd H. L. Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone. J Clin Endocrinol Metab. 1979 Nov;49(5):672–676. doi: 10.1210/jcem-49-5-672. [DOI] [PubMed] [Google Scholar]
  2. Bonneterre J., Coppens H., Mauriac L., Metz M., Rouesse J., Armand J. P., Fargeot P., Mathieu M., Tubiana M., Cappelaere P. Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day. Eur J Cancer Clin Oncol. 1985 Oct;21(10):1153–1158. doi: 10.1016/0277-5379(85)90007-0. [DOI] [PubMed] [Google Scholar]
  3. Brodie A. M., Garrett W. M., Hendrickson J. R., Tsai-Morris C. H., Marcotte P. A., Robinson C. H. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo. Steroids. 1981 Dec;38(6):693–702. doi: 10.1016/0039-128x(81)90087-8. [DOI] [PubMed] [Google Scholar]
  4. Cash R., Brough A. J., Cohen M. N., Satoh P. S. Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial. J Clin Endocrinol Metab. 1967 Sep;27(9):1239–1248. doi: 10.1210/jcem-27-9-1239. [DOI] [PubMed] [Google Scholar]
  5. Cohen M. P. Aminoglutethimide inhibition of adrenal desmolase activity. Proc Soc Exp Biol Med. 1968 Apr;127(4):1086–1090. doi: 10.3181/00379727-127-32877. [DOI] [PubMed] [Google Scholar]
  6. Cunningham D., Powles T. J., Dowsett M., Hutchison G., Brodie A. M., Ford H. T., Gazet J. C., Coombes R. C. Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer. Cancer Chemother Pharmacol. 1987;20(3):253–255. doi: 10.1007/BF00570496. [DOI] [PubMed] [Google Scholar]
  7. DAO T. L., TAN E., BROOKS V. A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinoma. Cancer. 1961 Nov-Dec;14:1259–1265. doi: 10.1002/1097-0142(196111/12)14:6<1259::aid-cncr2820140616>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  8. Dexter R. N., Fishman L. M., Ney R. L., Liddle G. W. Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action. J Clin Endocrinol Metab. 1967 Apr;27(4):473–480. doi: 10.1210/jcem-27-4-473. [DOI] [PubMed] [Google Scholar]
  9. Dowsett M., Cantwell B., Lal A., Jeffcoate S. L., Harris A. L. Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin. J Clin Endocrinol Metab. 1988 Apr;66(4):672–677. doi: 10.1210/jcem-66-4-672. [DOI] [PubMed] [Google Scholar]
  10. Dowsett M., Harris A. L., Stuart-Harris R., Hill M., Cantwell B. M., Smith I. E., Jeffcoate S. L. A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients. Br J Cancer. 1985 Oct;52(4):525–529. doi: 10.1038/bjc.1985.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Edery M., Goussard J., Dehennin L., Scholler R., Reiffsteck J., Drosdowsky M. A. Endogenous oestradiol-17beta concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: relationship to receptor content. Eur J Cancer. 1981 Jan;17(1):115–120. doi: 10.1016/0014-2964(81)90220-6. [DOI] [PubMed] [Google Scholar]
  12. Fishman J., Nisselbaum J. S., Menendez-Botet C. J., Schwartz M. K. Estrone and estradiol content in human breast tumors: relationship to estradiol receptors. J Steroid Biochem. 1977 Aug;8(8):893–896. doi: 10.1016/0022-4731(77)90100-5. [DOI] [PubMed] [Google Scholar]
  13. Fishman L. M., Liddle G. W., Island D. P., Fleischer N., Küchel O. Effects of amino-glutethimide on adrenal function in man. J Clin Endocrinol Metab. 1967 Apr;27(4):481–490. doi: 10.1210/jcem-27-4-481. [DOI] [PubMed] [Google Scholar]
  14. Foster A. B., Jarman M., Leung C. S., Rowlands M. G., Taylor G. N., Plevey R. G., Sampson P. Analogues of aminoglutethimide: selective inhibition of aromatase. J Med Chem. 1985 Feb;28(2):200–204. doi: 10.1021/jm00380a009. [DOI] [PubMed] [Google Scholar]
  15. Fracchia A. A., Farrow J. H., Miller T. R., Tollefsen R. H., Greenberg E. J., Knapper W. H. Hypophysectomy as compared with adrenalectomy in the treatment of advanced carcinoma of the breast. Surg Gynecol Obstet. 1971 Aug;133(2):241–246. [PubMed] [Google Scholar]
  16. Goss P. E., Powles T. J., Dowsett M., Hutchison G., Brodie A. M., Gazet J. C., Coombes R. C. Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report. Cancer Res. 1986 Sep;46(9):4823–4826. [PubMed] [Google Scholar]
  17. Grodin J. M., Siiteri P. K., MacDonald P. C. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973 Feb;36(2):207–214. doi: 10.1210/jcem-36-2-207. [DOI] [PubMed] [Google Scholar]
  18. HUGGINS C., DAO T. L. Y. Adrenalectomy and oophorectomy in treatment of advanced carcinoma of the breast. J Am Med Assoc. 1953 Apr 18;151(16):1388–1394. [PubMed] [Google Scholar]
  19. Harris A. L., Dowsett M., Smith I. E., Jeffcoate S. L. Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer. Br J Cancer. 1983 May;47(5):621–627. doi: 10.1038/bjc.1983.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Harvey H. A., Lipton A., White D. S., Santen R. J., Boucher A. E., Shafik A. S., Dixon R. J. Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer. Cancer Res. 1982 Aug;42(8 Suppl):3451s–3453s. [PubMed] [Google Scholar]
  21. Höffken K., Kempf H., Miller A. A., Miller B., Schmidt C. G., Faber P., Kley H. K. Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer. Cancer Treat Rep. 1986 Oct;70(10):1153–1157. [PubMed] [Google Scholar]
  22. KOFMAN S., NAGAMANI D., BUENGER R. E., TAYLOR S. G., 3rd The use of prednisolone in the treatment of disseminated breast carcinoma. Cancer. 1958 Jan-Feb;11(1):226–232. doi: 10.1002/1097-0142(195801/02)11:1<226::aid-cncr2820110135>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  23. Kirschner M. A., Cohen F. B., Ryan C. Androgen-estrogen production rates in postmenopausal women with breast cancer. Cancer Res. 1978 Nov;38(11 Pt 2):4029–4035. [PubMed] [Google Scholar]
  24. LUFT R., OLIVECRONA H., SJOGREN B. Hypofysektomi på människa. Nord Med. 1952 Mar 14;47(11):351–354. [PubMed] [Google Scholar]
  25. Lipton A., Harvey H. A., Santen R. J., Boucher A., White D., Bernath A., Dixon R., Richards G., Shafik A. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer. Cancer Res. 1982 Aug;42(8 Suppl):3434s–3436s. [PubMed] [Google Scholar]
  26. Lipton A., Santner S. J., Santen R. J., Harvey H. A., Feil P. D., White-Hershey D., Bartholomew M. J., Antle C. E. Aromatase activity in primary and metastatic human breast cancer. Cancer. 1987 Feb 15;59(4):779–782. doi: 10.1002/1097-0142(19870215)59:4<779::aid-cncr2820590419>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  27. Lønning P. E., Kvinnsland S. Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer. Drugs. 1988 Jun;35(6):685–710. doi: 10.2165/00003495-198835060-00005. [DOI] [PubMed] [Google Scholar]
  28. Lønning P. E., Kvinnsland S., Thorsen T., Ueland P. M. Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Preliminary findings. Clin Pharmacokinet. 1987 Dec;13(6):393–406. doi: 10.2165/00003088-198713060-00004. [DOI] [PubMed] [Google Scholar]
  29. McNeill J. M., Reed M. J., Beranek P. A., Bonney R. C., Ghilchik M. W., Robinson D. J., James V. H. A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women. Int J Cancer. 1986 Aug 15;38(2):193–196. doi: 10.1002/ijc.2910380208. [DOI] [PubMed] [Google Scholar]
  30. Millington D., Jenner D. A., Jones T., Griffiths K. Endogenous steroid concentrations in human breast tumours determined by high-resolution mass fragmentography. Biochem J. 1974 May;139(2):473–475. doi: 10.1042/bj1390473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Newsome H. H., Brown P. W., Terz J. J., Lawrence W., Jr Medical and surgical adrenalectomy in patients with advanced breast carcinoma. Cancer. 1977 Feb;39(2):542–546. doi: 10.1002/1097-0142(197702)39:2<542::aid-cncr2820390224>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  32. O'Neill J. S., Elton R. A., Miller W. R. Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br Med J (Clin Res Ed) 1988 Mar 12;296(6624):741–743. doi: 10.1136/bmj.296.6624.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Reed M. J., Beranek P. A., Ghilchik M. W., James V. H. Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer. Eur J Cancer Clin Oncol. 1986 Nov;22(11):1395–1400. doi: 10.1016/0277-5379(86)90151-3. [DOI] [PubMed] [Google Scholar]
  34. SEGALOFF A., WEETH J. B., RONGONE E. L., MURISON P. J., BOWERS C. Y. Hormonal therapy in cancer of the breast 16. The effect of Delta 1-testololactone on clinical course and hormonal excretion. Cancer. 1960 Sep-Oct;13:1017–1020. doi: 10.1002/1097-0142(196009/10)13:5<1017::aid-cncr2820130523>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  35. Samojlik E., Santen R. J. Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma. J Clin Endocrinol Metab. 1978 Oct;47(4):717–724. doi: 10.1210/jcem-47-4-717. [DOI] [PubMed] [Google Scholar]
  36. Samojlik E., Santen R. J., Wells S. A. Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels. J Clin Endocrinol Metab. 1977 Sep;45(3):480–487. doi: 10.1210/jcem-45-3-480. [DOI] [PubMed] [Google Scholar]
  37. Santen R. J., Lipton A., Kendall J. Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism. JAMA. 1974 Dec 23;230(12):1661–1665. [PubMed] [Google Scholar]
  38. Santen R. J., Santner S. J., Tilsen-Mallett N., Rosen H. R., Samojlik E., Veldhuis J. D. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor. Cancer Res. 1982 Aug;42(8 Suppl):3353s–3359s. [PubMed] [Google Scholar]
  39. Santen R. J., Santner S., Davis B., Veldhuis J., Samojlik E., Ruby E. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J Clin Endocrinol Metab. 1978 Dec;47(6):1257–1265. doi: 10.1210/jcem-47-6-1257. [DOI] [PubMed] [Google Scholar]
  40. Santen R. J., Worgul T. J., Samojlik E., Interrante A., Boucher A. E., Lipton A., Harvey H. A., White D. S., Smart E., Cox C. A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. N Engl J Med. 1981 Sep 3;305(10):545–551. doi: 10.1056/NEJM198109033051003. [DOI] [PubMed] [Google Scholar]
  41. Schieweck K., Bhatnagar A. S., Matter A. CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo. Cancer Res. 1988 Feb 15;48(4):834–838. [PubMed] [Google Scholar]
  42. Smith I. E., Harris A. L., Morgan M., Ford H. T., Gazet J. C., Harmer C. L., White H., Parsons C. A., Villardo A., Walsh G. Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. Br Med J (Clin Res Ed) 1981 Nov 28;283(6304):1432–1434. doi: 10.1136/bmj.283.6304.1432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Thompson E. A., Jr, Siiteri P. K. The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem. 1974 Sep 10;249(17):5373–5378. [PubMed] [Google Scholar]
  44. Vermeulen A., Paridaens R., Heuson J. C. Effects of aminoglutethimide on adrenal steroid secretion. Clin Endocrinol (Oxf) 1983 Dec;19(6):673–682. doi: 10.1111/j.1365-2265.1983.tb00044.x. [DOI] [PubMed] [Google Scholar]
  45. Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab. 1976 Feb;42(2):247–253. doi: 10.1210/jcem-42-2-247. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES